Bile acids, which are synthesized in the liver from cholesterol, are important in the production of bile flow, excretion of cholesterol, and intestinal digestion and absorption of fats and fat-soluble vitamins. Increases and/or alterations in concentrations of bile acids in serum are specific and sensitive indicators of hepatobiliary disorders. Synthesis of bile acids in hepatocytes involves steps in endoplasmic reticulum, cytosol, mitochondria, and peroxisomes. Other important hepatocellular processes involving bile acids include active uptake by the basolateral membrane, intracellular transport, P-450-mediated conjugations and hydroxylations, and canalicular secretion. Hydrophobic bile acids produce hepatotoxicity in vivo and in vitro. In experimental and epidemiologic studies, some of these forms have been identified as causative agents in the development of colon and liver (experimental only) cancer. Conversely, several hydrophilic forms, primarily ursodeoxycholic acid, have demonstrated cytoprotective properties in a variety of clinical and experimental hepatobiliary diseases and disorders. Because bile acids can have dramatically different properties and effects, determination of mechanisms of action of these compounds has become an active area of research. Primary isolated hepatocytes provide an opportunity to investigate bile acid-related functions and effects in well-designed, carefully controlled studies. Short-term cultures have been used to study a variety of issues related to bile acids, including cytotoxicity, synthesis, and hepatocellular processing. With these systems, however, many functions of mature hepatocytes, including those pertaining to bile acids, can be lost when cultures are maintained for more than several days. Recent developments in culture techniques permit long-term maintenance of functionally stable, differentiated cells. Pertaining to bile acid research, these systems remain to be fully characterized but, in appropriate situations, they should provide important alternatives to in vivo studies and short-term in vitro assays.
INTRODUCTION
Bile acids are synthesized in the liver from cholesterol, secreted into bile, and efficiently conserved within the enterohepatic circulation. Increases in concentrations in serum are consistent with congenital or acquired hepatobiliary disorders. The latter can be produced by drugs and chemicals (including bile acids) and physical, biochemical, and environmental factors. In appropriate situations, changes in bile acids can provide specific information pertaining to alterations in hepatocellular function. The ability to interpret and use this information, however, requires an understanding of principles of bile acid synthesis and processing by the liver. These issues will be addressed briefly with emphasis on the various steps performed at the cellular level.
An additional consideration in bile acid research is selection of an appropriate experimental model. In vivo and in vitro systems are used that have inherent advantages and disadvantages. Ideally, selection should be based on the types of studies being conducted and strengths of the model. For example, determinations of effects of a treatment on bile acids within the enterohepatic circulation, on bile flow, or on toxicologic or carcinogenic consequences of changes in concentrations of endogenous bile acids would be conducted in vivo. Alternatively, studies of bile acid uptake, metabolism, or synthesis can be con-ducted effectively with isolated hepatocytes or subcellular preparations. In the following sections, findings from in vitro studies, specifically those using primary isolated hepatocytes, will be emphasized. RELEVANCE 
Physiologic Functions
Bile acids are the predominant organic constituent in bile (114) . They are secreted by hepatocytes into canalicular lumina along with a cation (primarily Na+) to maintain electroneutrality. Concentrations in bile exceed those in serum by more than 1,000-fold. In canaliculi, bile acids are responsible for the passive accumulation of small inorganic cations and water by paracellular diffusion (57) . Canalicular bile produced by the process of bile acid secretion is termed bile acid dependent flow (BADF) and is the major component of total bile flow (TBF). Total canalicular flow is the sum of BADF and bile acid independent flow (BAIF)-that portion not associated with bile acid secretion. Glutathione secretion appears to be an important determinant of BAIF (10) .
TBF is the sum of canalicular and ductular secretions.
Relative to human beings, TBF in the rat is approximately 12-fold greater (57) .
Bile acids are amphiphilic compounds with hydrophilic (hydroxyl groups and ionized carboxyl group or conjugated amino acid) and hydrophobic (steroid nucleus) domains that determine physical and chemical properties of the molecules (23) . Because of these water-soluble and lipid-soluble characteristics, bile acid molecules orient at water-lipid interfaces, decrease surface tension, and, consequently, function as effective biological detergents.
Above critical concentrations, bile acids aggregate into micelles that have water-soluble exteriors and lipid-soluble cores. These particles form mixed micelles in bile through the incorporation of lipids such as cholesterol and phospholipids into the hydrophobic center. In the small intestines, dietary cholesterol, triglycerides, and products of lipid digestion are incorporated into micelles. This process further promotes enzymatic digestion and enhances the delivery of fats and fat-soluble vitamins to the intestinal mucosa. In the absence or reduction of intestinal bile acids (e.g., in severe intraor extrahepatic cholestasis), steatorrhea and deficiencies in fat-soluble vitamins can develop.
DetectionlDiagnosis of Hepatobiliary Disease
Bile acid concentrations in serum are highly specific and moderately sensitive indicators of many induced and acquired hepatobiliary diseases in human beings and domestic and laboratory animals (25, 72, 95, 99, 130) . Most bile acid changes-typically increases-are associated with processes that interfere with the flow or production of bile (cholestasis). These can be classified into extracellular (extra-and intrahepatic) and cellular mechanisms. Extrahepatic and intrahepatic processes have sim- ilar etiologies and effects and include those that produce physical disruptions and/or obstructions of bile flow through the biliary system. Causes include cholelithiasis, inflammation, tumors, parasites, congenital and acquired lesions of bile ducts, and drug actions and interactions that obstruct (e.g., through precipitation of compounds) or damage (e.g., through direct toxicity) the biliary tract.
Other extracellular causes of increased serum concentrations include congenital or acquired portosystemic vascular anomalies that result in the shunting of portal blood past the hepatic parenchyma.
Increases in serum concentrations of bile acids also can be produced by processes that produce cholestasis at the cellular level (Table I) . Ultimately, these processes produce increases in serum bile acid concentrations through several common mechanisms. These include decreased uptake of bile acids from blood, leakage from canalicular lumina into blood through compromised tight junctions, and reflux of intracellular concentrations back across the basolateral membrane into sinusoids. Drugs in a variety of categories, including antimicrobial, hypoglycemic, anticancer, steroid, antiinflammatory, anticonvulsant, psychiatric, and cardiovascular, can produce acute cholestasis (92) .
Ratios of groups of bile acids and profiles of individual forms in serum can provide diagnostic information about hepatobiliary diseases (24, 84) . In cholestatic diseases, concentrations of trihydroxylated bile acids often exceed those of mono-and dihydroxylated forms and ratios are > 1.0. Conversely, in chronic hepatocellular diseases, synthesis of trihydroxylated bile acids often is impaired and ratios are typically < 1.0. Unfortunately, there is overlapping between these groups and the usefllll1c&dquo;&dquo; of this approach appears limited (95) . An exception, however, occurs with liver transplantation, in which total and individual serum bile acid concentrations can be more sensitive than traditional liver tests for detection of early graft rejection (50) .
T oxicity/ Carcinogenicity
Considerable efforts have been made to characterize toxic and carcinogenic effects of bile acids and to understand underlying mechanisms (Table II ). In numerous in vim and in uitt-o studies. hydrophobic bile acids have been toxic to hepatocytes. Although bile acids can initiate and perpetuate hepatocellular injury at biologicallp relevant concentrations, caution I, required in the interpretation of results from many studies. Those in which high (101, 118) . These findings are supported by experimental studies in which orally or rectally administered bile acids have promoted the formation of colon tumors in chemically initiated rats (71, 102) . Hydrophobic primary and secondary bile acids also have enhanced the formation of preneoplastic foci in the liver of rodents (18, 22) . Mechanisms for tumor promotion by bile acids may involve increased cellular turnover secondary to toxicity or increased proliferation due to changes in intracellular signals mediated by activation of protein kinase C (17, 21, 28, 35, 55, 96) .
Cytoprotection
In contrast to toxic and carcinogenic effects of hydrophobic bile acids, some hydrophilic forms have therapeutic and, potentially, anticarcinogentic properties. Ursodeoxycholic acid (UDCA), for example, is being used in the treatment of a variety of clinical and experimental hepatobiliary disorders (Table III) . Beneficial effects frequently include improvements in clinical, biochemical, and histopathological variables. Also, in a recent experimental study, dietary UDCA decreased formation of colon tumors in rats treated with azomethane alone and in those receiving azomethane and cholic acid (40) . Numerous mechanisms have been proposed for these cytoprotective properties of UDCA (15, 51, 98, 107, 128) . Consistent effects include increases in the production of bile (choleresis), decreases in intracellular concentrations of toxic bile acids, enhanced bile acid transport, decreases in the overexpression of major histocompatibility class I antigens, stabilization of plasma membranes, and Ca++dependent stimulation of vesicular exocytosis. More research is needed to characterize chemopreventive and therapeutic properties of UDCA, however, because of recent findings, this bile acid has become an important drug in the treatment of hepatobiliary diseases.
HEPATIC PROCESSING
The term processing refers to uptake, intracellular transport, metabolism, and secretion of bile acids by he-patocytes ( Fig. 1 ). With the inclusion of synthesis, these are the major areas of hepatocyte function pertaining to bile acids. Each will be discussed briefly.
Synthesis
The traditional or neutral pathway of de novo synthesis of bile acids from cholesterol occurs exclusively in hepatocytes and involves a series of highly integrated biochemical steps that occur in microsomes, cytosol, mitochondria, and peroxisomes (Fig. 2 ). In short-term cultures, rat hepatocytes synthesized primary bile acids at rates approximately one-half those measured in vivo (33) . Synthesis is regulated by the control enzyme, microsomal cholesterol 7a-hydroxylase. Feedback inhibition by bile acids on cholesterol 7&OElig;-hydroxylase was proposed in 1958 (14) and has been confirmed in numerous in vivo studies (52, 54, 119) . Hydrophobic bile acids transcriptionally downregulate cholesterol 7a-hydroxylase while cholesterol, thyroxine, and dexamethazone produce transcriptional upregulation of the enzyme (61) . Feedback inhibition also has been demonstrated in cultured rat hepatocytes using medium supplemented with thyroxine and dexamethasone (123) . In the human hepatoma cell line, Hep-G2, transcriptional regulation of the cholesterol 7&OElig;-hydroxylase gene also has been produced by bile acids (.J,.), cholesterol (I), and thyroxine and dexamethasone (T) (32, 126) .
Primary bile acids, of which cholic acid (CA) and chenodeoxycholic acid (CDCA) are the major forms, are synthesized from cholesterol. Secondary bile acids are produced by bacterial modification of primary forms in the intestines, and tertiary bile acids result from the metabolism of secondary forms returned to the liver via the portal circulation. Bacterial dehydroxylation of CA and CDCA in the intestines produces deoxycholic acid (DCA) and lithocholic acid (LCA), respectively. The latter are more hydrophobic than their precursors and, potentially, more toxic. Rat hepatocytes synthesize primarily CA and r3-muricholic (3-MCA) acids with small amounts of CDCA, a-MCA, and Ô,22-r3-MCA (5, 39, 60) . In Hep-G2 cells, CDCA is synthesized at a rate more than 7-fold greater than that for CA due to a low level of microsomal 12a-hydroxylase (66) .
An alternate or acidic pathway for bile acid synthesis has been described in which the enzyme, sterol 27-hydroxylase, initiates the process of cholesterol metabolism through hydroxylation of the side chain (Fig. 2) (7, 64, 65) . This step occurs predominantly in extrahepatic tissues, especially vascular endothelium. 3p-hydroxy bile acids that are produced in this pathway may be metabolized to 3a-hydroxy forms in the liver (7) . 27-Hydroxycholesterol is a potent inhibitor of hepatic hydroxymethyl glutaryl coenzyme A reductase, the control enzyme for cholesterol synthesis. Compared to the traditional route of synthesis, this pathway produces relatively more CDCA than CA, and the former may be an important regulator of cholesterol 7a-hydroxylase in the traditional pathway. In human beings with hepatic disease (e.g., cirrhosis), synthesis of bile acids in the traditional pathway is decreased. This decrease, however, occurs primarily in CA and not CDCA, which may be maintained through FIG. I.-Schematic of hepatocyte in which the major steps in bile acid processing are represented. These include synthesis of bile acids from cholesterol, receptor-mediated uptake at the basolateral membrane, intracellular transport by cytoplasmic proteins, metabolism by microsomal P-450 enzymes, and canalicular secretion by transport proteins. Vectoral transport is dependent on maintaining the asymmetrical distribution of basolateral and canalicular proteins. the continued production of precursors from 27-hydroxycholesterol. In human beings, the disease cerebrotendinous xanthomatosis results from a hereditary deficiency of sterol 27-hydroxylase (65) .
Uptake
Bile acid uptake is a function performed by differentiated hepatocytes. Cells that undergo neoplastic transformation or are cultured using conventional techniques dedifferentiate and rapidly lose many specialized functions, including uptake (19, 81, 113) . The primary mechanism for bile acid uptake by hepatocytes is Na+-dependent cotransport by a 48-49-kDa protein located in the basolateral membrane. This protein is structurally similar to microsomal epoxide hydrolase (133) . Bile acids transported by this process are primarily conjugated trihydroxylated [taurocholic acid (TCA) and glycocholic acid] and, to a lesser degree, dihydroxylated forms. The electrochemical ion gradient for uptake is generated by the NaT,KT-ATI~ase pump, which exports 3 Na-in exchange for 2 K+. A 54-kDa transport protein also has been identified that is NaT-independent and transports unconjugated bile acids (e.g., CA) in addition to other organic anions (114) . Monohydroxylated and some dihydroxylated unconjugated bile acids are taken up primarily by non-ionic passive diffusion. Unlike the previously described mechanisms, this one is not concentrative.
Bile acid uptake by hepatocytes is a rapid process. Using fresh suspensions or cultures, radiolaheled bile acids are transported across the basolateral membrane into the cells within seconds (62) . Uptake experiments typically last 1 min with time points every 15 sec. Uptake is measured by the activity of radiolabeled compound in the cells expressed as rate of accumulation per amount of cellular protein. Uptake of bile acids into tsuiatcd hcl~atocytes has been inhibited by other bile acid, ( 1_1,). 1,1,1trichloroethane (76), tetrachloroethylene (7f~ j. cpclosporin A (8, 77) , and trichloroethylene (9) and by formation of carcinogen-induced diploid and y-glutamvltranspeptidase-positive hepatocytes (8I , 1 13 ). Treatment with cyclosporin A and exposure to trichloroethylc~n~ has been associated with increased concentrations of serum bile acids in human beings and laboratory animals.
Intracellular Transport
Once in hepatocytes, bile acids are bound to carrier proteins for direct and, often, indirect transport to the apical (canalicular) pole. Concerning the latter, interactions with intracellular compartments such as endoplasmic reticulum are necessary if metabolism of recirculat-FIG. 2.-Established and potential pathways for bile acid synthesis from cholesterol (taken, in part, from refs 7, 64, and 66). Traditional or neutral pathway is regulated by the microsomal enzyme cholesterol 7a-hydroxylase. This pathway occurs exclusively in the liver and is downregulated by bile acids and upregulated by cholesterol. The acidic pathway, which is initiated by 27-hydroxylation of cholesterol, provides precursors for bile acid synthesis in the liver and results in the formation of more CDCA than CA. 27-Hydroxycholesterol inhibits hepatic hydroxymethyl glutaryl coenzyme A reductase, the control enzyme for cholesterol synthesis. ing bile acids is to occur. Using fluorinated derivatives, bile acids have been localized to membranes of the endoplasmic reticulum and Golgi apparatus during transport through isolated hepatocytes (29) . Cytoplasmic transport proteins include 3a-and 3 P-hydroxy steroid dehydrogenase (3a-and 3P-HSD), glutathione S-transferase, and fatty acid binding protein (121, 136) . Carrier proteins also prevent reflux of bile acids back across the plasma membrane, metabolize 3-oxo-bile acids, and prevent partitioning into intracellular compartments. 3a-HSD, the primary carrier, and to an unknown extent, 3(3-HSD, metabolize 3-oxo-bile acids to appropriate 3aand 30-hydroxylated forms.
In situations of high bile acid load, microtubular-dependent vesicular transport becomes an important mechanism for moving bile acids across the hepatocyte (30) . Several bile acids, including TCA, UDCA, and tauroursodeoxycholic acid increase tubulovesicular transport of horseradish peroxidase (108, 109) . The stimulatory effect of bile acids on canalicular secretion in part may be related to microtubular-dependent insertion of a bile acid carrier into the canalicular membrane by hydrophobic bile acids (31 ) . Colchicine, a compound that inhibits microtubule formation, decreases intracellular bile acid transport during high bile acid flux but has little effect during basal flow.
3a-HSD is potently inhibited by nonsteroidal antiinflammatory drugs and, in the rat, is identical to dihydrodiol dehydrogenase, an enzyme that decreases formation of the ultimate carcinogen for some polycyclic aromatic hydrocarbons. Addition of 3aor 3-oxo-bile acids to perfusate of isolated perfused liver or to medium of isolated hepatocytes (3-oxo) in combination with inhibition of 3a-HSD by indomethacin decreased uptake of the bile acid, increased the amount of unbound bile acid in cytoplasm, and delayed the appearance of the bile acid in bile (124, 125) . Alterations in functions of bile acid carriers may have important implications for bile acid toxicity and carcinogenicity.
Metabolism
During passage through the hepatocyte, secondary bile acids may be reduced and/or hydroxylated (type I biotransformation) and conjugated (type II biotransformation) by microsomal enzymes. Typically, the resulting bile acids are more water-soluble, more readily excreted, and less toxic than the precursors. These metabolic steps generally involve addition of hydroxyl groups to the steroid nucleus and an amino acid, typically glycine or taurine, to the acyl side chain. In human beings, sulfation and glucuronidation are important type II reactions (57) . Although conjugation is not an essential step, it does increase the rate of canalicular secretion of some bile acids (138) . In the rat, recirculating bile acids frequently may be hydroxylated in the liver at the 6(3 and 7(3 positions.
Additionally, an existing 7a-hydroxyl group often is epimerized to the 7p position. Resulting bile acids are diand trihydroxylated forms that can include deoxymuricholic (3a,6(3-diol), UDCA (3a,7(3-diol), a-MCa (3a,6(3,7a-triol), and I3-MCA (3&OElig;,613,713-triol). Recent ift vitro and in vivo studies also have identified major hepatocellular metabolites of ~3-MCA and UDCA that are unsaturated at carbon 22 in the side chain (115, 131) .
These IA22 bile acids may be formed by an incomplete attempt to cycle these original bile acids through a second round of p-oxidation in peroxisomes.
Canalicular Secretion
The rate-limiting event for bile acid secretion is transport across the canalicular membrane. This occurs by electrogenic (135) and adenosine triphosphate (ATP)-dependent processes (2, 88) . Although the latter has been identified only recently, quantitatively, it appears to be the more important mechanism. In a recent study, only ATP-dependent transport was found in canalicular membrane vesicles, whereas electrogenic transport of TCA was confined to the endoplasmic reticulum (68) .
A 100-110-kDa protein that has similarities to canalicular ecto-ATPase has been identified as a bile acid transporter in the canalicular membrane (12) . This protein, as with other integral canalicular and basolateral proteins and with those synthesized for constitutive secretion, initially is transported in vesicles from the Golgi apparatus to the plasma membrane (6, 11, 110) . Unlike the others, however, canalicular proteins are reprocessed and transported in vesicles back across the cytoplasm to the apical pole (86) . This step, which is also used for transport of polymeric IgA and horseradish peroxidase, is microtubule-dependent and colchicine-sensitive (39) . During cholestasis, transcytotic vesicular transport is impaired and canalicular proteins accumulate in pericanalicular vesicles and/or remain in the basolateral membrane (46, 120) . In the latter location, bile acids can be actively transported from the cell into sinusoidal blood resulting in an increase in serum concentrations during cholestasis. During the preparation of isolated hepatocytes for in vitro studies, tight junctions are disrupted and canalicular membrane proteins accumulate in the basolateral membrane. This creates a situation similar to the one just described for cholestasis in which bile acids can be transported back across the basolateral membrane. In vitro, this process is referred to as efflux and should be distinguished from secretion, which is a canalicular event. In hepatocytes cultured using conventional techniques, however, reformation of canaliculi can reestablish vectoral flow. Evaluation of efflux/secretion involves preloading hepatocytes with a radiolabeled bile acid and measuring the rate of appearance of bile acid in the medium (78) . With hepatocyte cultures or suspensions in conventional medium (contains Na+), this process can be confounded by the reuptake of previously effluxed bile acids. A variety of compounds, some of which produce cholestasis in vivo, interfere with bile acid efflux in vitro. These include chlorpromazine (136) , cyclosporin A (4), inhibition of ATP-dependent transport (by cyclosporin A) (20) , bile duct ligation (127) , ethinylestradiol (127) , and activation of protein kinase C (91).
ADDITIONAL CONSIDERATIONS
Even though significant progress has been made in the use of primary hepatocyte cultures to study bile acid pro-cesses. important issues remain. In effect. there may be limitations in the use of conventional collagen-coat culture systems. For example. uptake of bile acids by hepatocytes is a hishh specific function. With conventional culture systems, however. uptake of TCA at 6 hr was 60% of control values from freshly isolated hepatocytes, 40% at 20 hr, 15% at 48 hr. and 0% at 72 hr (43, 75) .
Because of impaired uptake, secretion of transported bile acids decreases to very low levels beyond 24 hr. Hepatocytes cultured on collagen-coated plates spread extensively and have minimal lateral membrane contact with adjacent cells (82) . Additionally, gap junctional microfilaments are disrupted and bile canaliculi are poorly formed. Similar to processes that occur with cholestasis, canalicular proteins remain in the basolateral membrane, and vectoral transport of bile acids can be lost or impaired. Efflux of bile acids becomes a predominant process, and the significance of results in such situations should be questioned. Maintenance of other processes, including intracellular transport, metabolism, and synthesis is problematic. Conventionally cultured hepatocytes lose most specific functions within a week and assume a dedifferentiated condition similar to fetal hepatocytes (48) . These effects appear to result from loss of transcription of liver-specific genes. The limitations of each step should be defined before studies using this or any other system are conducted.
A number of culture systems maintain cell viability and liver-specific functions. One such system is the collagen gel sandwich (CGS) (38, 41, 82) . With this method, hepatocytes are plated on a layer of collagen gel, allowed to attach, and later covered with a second layer of gel. The bipolar exposure of cells to extracellular matrix proteins results in organization of actin filaments beneath the plasma membrane at points of cell-cell contact. Hepatocytes assume a normal-appearing 3-dimensional shape with extensive lateral membrane contact. Active cell-cell communication and a functional, anastamosing bile canalicular network develop. Furthermore, retention of cell shape and organization of microfilaments appear to be associated with maintenance of liver-specific gene transcription.
Hepatocytes cultured in the CGS maintain a variety of cell-specific functions. For example, at 6 wk of culture, albumin synthesis was high and stable and levels of albumin messenger RNA were similar to those in freshly isolated cells. Additionally, transcriptional activity for albumin was 40% of normal liver at 21 days of culture. Levels for the latter were barely detectable in single-layer collagen preparations at 7 days. Total bile acid secretion by hepatocytes in the CGS was stable at 42 days of culture (91) . In a culture system in which hepatocytes were cocultured with a liver cell line. bile acid uptake was stable for 56 days at approximately one-half the value obtained at 48 hr (42) . Full characterization of the CGS system with respect to bile acid-related processes )s being performed.
SUMMARY
Bile acids have important biological function. that include the generation of bile flow, elimination ot ~h~~lc5-terol. and enhancement of intestinal digestion and absorption of lipids and fat-soluble vitamins. Clinically and experimentally, increases in bile acid concentrations in serum are indicative of altered hepatobiliary function. This occurs because bile acids are processed by hepatocytes in a complex sequence of events that involves synthesis, uptake, metabolism, transport, and secretion. In addition to bile acids being indicators of hepatobiliary integrity, they can initiate and enhance hepatocellular damage and promote colon and liver carcinogenesis. Conversely, hydrophilic forms can be cytoprotective and are being used to treat hepatobiliary disorders in human beings and domestic and laboratory animals. In conventional culture systems, hepatocytes rapidly dedifferentiate and, consequently, experiments examining bile acid processes can be conducted for only short periods of time. For studies requiring long-term cultures, new techniques are being explored that promote maintenance of differentiated cells that retain functions specific to bile acid processing.
